- Home
- NRXP vs TRAD Comparison
NRXP vs TRAD Comparison
Compare NRXP & TRAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.45
Company Overview
Basic Information| Metric | NRXP | TRAD |
|---|---|---|
| Founded | 2015 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 147.8M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NRXP | TRAD |
|---|---|---|
| Price | $2.45 | $10.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.75 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 53.6K |
| Earning Date | 11-24-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,225,000.00 | N/A |
| Revenue This Year | $357.94 | N/A |
| Revenue Next Year | $1,281.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $9.93 |
| 52 Week High | $5.06 | $10.13 |
Technical Indicators
Market Signals| Indicator | NRXP | TRAD |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 58.78 |
| Support Level | $1.68 | $9.99 |
| Resistance Level | $2.49 | N/A |
| Average True Range (ATR) | 0.22 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 50.00 | 66.67 |
Price Performance
Historical Comparison NRXP
TRAD
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About TRAD APEX Tech Acquisition Inc. Ordinary Shares
APEX Tech Acquisition Inc is a blank check company.